Accéder au contenu
Merck

Simple di- and trivanillates exhibit cytostatic properties toward cancer cells resistant to pro-apoptotic stimuli.

Bioorganic & medicinal chemistry (2010-05-15)
Delphine Lamoral-Theys, Laurent Pottier, Frédéric Kerff, François Dufrasne, Fabien Proutière, Nathalie Wauthoz, Philippe Neven, Laurent Ingrassia, Pierre Van Antwerpen, Florence Lefranc, Michel Gelbcke, Bernard Pirotte, Jean-Louis Kraus, Jean Nève, Alexander Kornienko, Robert Kiss, Jacques Dubois
RÉSUMÉ

A series of 33 novel divanillates and trivanillates were synthesized and found to possess promising cytostatic rather than cytotoxic properties. Several compounds under study decreased by >50% the activity of Aurora A, B, and C, and WEE1 kinase activity at concentrations <10% of their IC(50) growth inhibitory ones, accounting, at least partly, for their cytostatic effects in cancer cells and to a lesser extent in normal cells. Compounds 6b and 13c represent interesting starting points for the development of cytostatic agents to combat cancers, which are naturally resistant to pro-apoptotic stimuli, including metastatic malignancies.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Vanillic acid, 97%
Sigma-Aldrich
Methyl vanillate, 99%
Sigma-Aldrich
Vanillic acid, ≥97%, FG
Sigma-Aldrich
Vanillic acid, purum, ≥97.0% (HPLC)